Abstract: This invention relates to a new stationary phase carrying functional groups comprising a halogen substituted aromatic ring. Target molecules can interact with this stationary phase by halogen bonding. The stationary phase is suitable for SPE or chromatographic separations.

Abstract: The present invention relates to spiro compounds containing electron-conducting groups and to electronic devices, in particular organic electroluminescent devices, comprising these compounds.

Abstract: The present invention relates to a method for synthesizing a semiconducting nanosized material.

Abstract: An electrically switchable optical modulator for modulating an optical wavefront transmitted therethrough, comprising a birefringent first optical element and a birefringent second optical element each having respective ordinary and extraordinary refractive indices. A birefringent liquid crystal material is sandwiched between the first and second optical elements. The extraordinary refractive index of the liquid crystal material is electrically switchable between: a first state in which it has a first value; and, a second state in which it has a second value different from the first value. One or both of the first value and the second value is un-matched to the extraordinary refractive index of the first optical element in respect of light polarised in a first direction of linear polarisation, and is un-matched to the extraordinary refractive index of the second optical element in respect of light polarised in a second direction of linear polarisation orthogonal to the first direction.

Abstract: The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors.

Abstract: The invention relates to compounds of the formula I, in which R, A, n, L1, L2, L3 and X have the meanings given in Claim 1, to a process for their preparation, and to liquid-crystalline media comprising at least one compound of the formula I and electro-optical displays containing a liquid-crystalline medium of this type.

Abstract: The present invention provides a method for preparing a pharmaceutical composition of a pharmaceutical ingredient (API) which is loaded on a carrier and stabilized therethrough. In particular, the present invention relates to a composition of a poorly soluble nanoparticulated API on a carrier in the dry state and which is processed as pharmaceutical formulation of said API with improved release profile and bioavailability.

Abstract: Disclosed is a device for the regulation of light transmission. In particular, switchable windows and methods for their preparation are disclosed. The switchable windows include electrically switchable devices which in one optical switching state are capable of portraying closed patterns or images without the need for providing complex electrical contacting.

Abstract: The present invention relates to cell culture media comprising N-lactoyl derivatives of one or more amino acid. The poor solubility of some amino acids in cell culture media is overcome by substituting them with an N-lactoyl derivative.

Abstract: The invention relates to heteroaromatic compounds, particularly for use in electronic devices. The invention further relates to a method for producing the compounds according to the invention and to electronic devices containing same.

Abstract: The present invention relates to novel compounds containing fluorinated end groups, to the use thereof as surface-active substances, and to compositions comprising these compounds.

Abstract: The present invention relates to a formulation containing at least one organic functional material and at least four different organic solvents, a first organic solvent A, a second organic solvent B, a third organic solvent C, and a fourth organic solvent D, wherein the first organic solvent A comprises a group, which is capable of receiving or giving a hydrogen bonding, the second organic solvent B has a boiling point in the range from 50 to 350° C., the third organic solvent C has a boiling point in the range from 100 to 300° C., and the fourth organic solvent D has a boiling point in the range from 200 to 400° C., is present in an amount from 0.01 to 1 vol.-% and has a viscosity of ?15 mPas, the solubility of the at least one organic functional material in the second organic solvent B and in the fourth organic solvent D is ?5 g/l, the boiling point of the third organic solvent C is at least 10° C.

Abstract: The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds.

Abstract: The present invention relates to iridium complexes suitable for use in organic electroluminescent devices, especially as emitters.

Abstract: The present invention relates to a process to produce compounds of the formula (1) which are suitable for use in electronic devices, as well as to intermediate compounds of formula (Int-1) and compounds of formula (1-1) and (1-2) obtained via the process. These compounds are particularly suitable for use organic electroluminescent devices. The present invention also relate to electronic devices, which comprise these compounds.

Abstract: The present invention describes diazadibenzofuran or diazadibenzothiophene derivatives substituted by carbazole, fluorene, phenanthrene, benzofuran and/or benzothiophene groups, especially for use in electronic devices. The invention further relates to a process for preparing the compounds of the invention and to electronic devices comprising these.

Abstract: The present invention relates to the use of flake-form effect pigments for increasing the infrared reflection of a dark or black layer composite, consisting of a substrate and a coating on the substrate, and to a dark or black layer composite of this type which has increased infrared reflection, in particular in the near infrared (NIR), compared with conventional dark or black layer composites which comprise only carbon-containing black pigments.

Abstract: The present invention relates to a laser additive comprising core/shell particles, to a process for the preparation of a laser additive of this type, and to the use thereof, in particular as laser absorber in plastics and plastic-containing coatings of articles.

Abstract: The present invention is directed to the use of the GDF-5 mutant with an amino acid exchange R399E for the treatment of cartilage defects and pain and a pharmacological composition of said GDF-5 mutant.

Abstract: A liquid-crystal (LC) medium containing one or more dyes and one or more polymerizable compounds, its use for optical, electro-optical and electronic purposes, in particular in LC displays, especially in colour LC displays of the PSA (polymer sustained alignment) or SA (self-aligning) mode containing a quantum dot colour filter (QDCF), an LC display of the PSA or SA mode containing the LC medium and containing a QDCF, and to a process of manufacturing the LC display.